The respiratory medical community is moving toward shared decision-making in self-managing chronic respiratory disease, but ...

Sulfite allergy occurs when your immune system is overly sensitive to sulfite. It can cause symptoms like itching, swelling, ...

STRUCK by a painful burn in your chest and throat, and a sour taste on your tongue? Chances are you’ve got heartburn, caused ...

Evidence is growing that psychedelics could hold the key to managing inflammation, one of the body’s central drivers of many ...

Gov. Gavin Newsom announced Thursday that the state would provide insulin shots for $11, far below market prices.

Beta blockers, traditionally used to treat high blood pressure, have become the go-to medication for anxiety — but they are ...

Lower-cost insulin manufactured by the state of California will be available to consumers starting Jan. 1, 2026, for about ...

America’s drug market rewards rebate checks, not real savings. Every player wins when list prices rise, except the patients ...

PresidentTrump announced a deal with AstraZeneca to cut drug prices for Americans while investing $50B in U.S. manufacturing.

In recent quarters, Duquesne has been selling AI winners like Nvidia (NASDAQ: NVDA) and Palantir Technologies (NASDAQ: PLTR) and piling into one of Wall Street's hottest drug stocks ahead of 2026.

The president’s call for removal of the metal from childhood inoculations set off alarms. About half of shots for polio, ...

The White House announced a new agreement with AstraZeneca to align U.S. drug prices with those of other developed nations under the administration’s most-favored-nation, or MFN, pricing initiative.